Mycophenolate Mofetil (MMF)

CEP and US-DMF for Mycophenolate Mofetil (MMF)

In cooperation with WUXI FORTUNE PHARMACEUTICAL Co, Ltd, Dolder has received the CEP for MMF. MMF is the only immunosuppressive with a proven, higher survival advantage and the fewest side effects.

Areas of application
MMF is an immunosuppressive that is used primarily in combination with cyclosporin for the prevention of acute rejection reactions in case of heart, liver, and kidney transplants. It unfolds its effect by preventing the proliferation of T and B lymphocites. MMF's own therapeutic benefit, e.g. for heart transplant patients, results from

• the increased survival advantage
• the reduction of coronary illnesses
• the reduction of side effects

Advantage for manufacturers
Like a catalyst, Dolder helps the producers with the mastery of regulatory bureaucracy. You save time, costs, and nerves.

Advantage for customers
Our experts directly on-site and in Switzerland guarantee transparency in the selection of our manufacturers, the highest GMP quality, and complete documentation. For our customers, this means:
Swiss quality at Asian prices - profit from this!